Abstract
Tumor necrosis factor (TNF) is a cytokine with well known anticancer properties and is being utilized as anticancer agent for the treatment of patients with locally advanced solid tumors. However, TNF role in cancer biology is debated. In fact, in spite of the wealth of evidence supporting its antitumor activity, the cascade of molecular events underlying TNF-mediated tumor regression observed in vivo is still incompletely elucidated. Furthermore, some preclinical findings suggest that TNF may even promote cancer development and progression. With this work we intend to summarize the molecular biology of TNF (with particular regard to its tumor-related activities) and review the experimental and clinical evidence currently available describing the complex and sometime apparently conflicting relationship between this cytokine, cancer biology and antitumor therapy. We also propose a model to explain the dual effect of TNF based on the exposure time and cytokine levels reached within the tumor microenvironment. Finally, we overview recent research findings that might lead to new ways for exploiting the anticancer potential of TNF in the clinical setting.
Keywords: Tumor necrosis factor, TNF, cancer, biology, therapy, chemotherapeutic agents, cancer biotherapy, Coley's toxin, TNF PATHWAY, TNF-converting enzyme, TACE, (DISC), transcription factors, (SODD), programmedcell-death, apoptosis, FLICE, ceramide, ANTICANCER, cathepsin-B, murine fibrosarcoma, haemorrhagic necrosis, thromosis, pro-coagulant tissue factor, NOS, antineoplastic agents, malignant cells, protein kinase-C, carcinogenesis, angiogenesis, Cancer anorexia-cachexia syndrome, single nucleotide polymorphisms, isolated limb perfusion, isolated hepatic perfusion, ANTI-TNF THERAPY, TNF-antagonists, TNF Muteins, NFkB Pathway, NFkB, proapoptotic factors, NSAID, PKB/Akt
Current Medicinal Chemistry
Title: The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology
Volume: 17 Issue: 29
Author(s): L. Bertazza and S. Mocellin
Affiliation:
Keywords: Tumor necrosis factor, TNF, cancer, biology, therapy, chemotherapeutic agents, cancer biotherapy, Coley's toxin, TNF PATHWAY, TNF-converting enzyme, TACE, (DISC), transcription factors, (SODD), programmedcell-death, apoptosis, FLICE, ceramide, ANTICANCER, cathepsin-B, murine fibrosarcoma, haemorrhagic necrosis, thromosis, pro-coagulant tissue factor, NOS, antineoplastic agents, malignant cells, protein kinase-C, carcinogenesis, angiogenesis, Cancer anorexia-cachexia syndrome, single nucleotide polymorphisms, isolated limb perfusion, isolated hepatic perfusion, ANTI-TNF THERAPY, TNF-antagonists, TNF Muteins, NFkB Pathway, NFkB, proapoptotic factors, NSAID, PKB/Akt
Abstract: Tumor necrosis factor (TNF) is a cytokine with well known anticancer properties and is being utilized as anticancer agent for the treatment of patients with locally advanced solid tumors. However, TNF role in cancer biology is debated. In fact, in spite of the wealth of evidence supporting its antitumor activity, the cascade of molecular events underlying TNF-mediated tumor regression observed in vivo is still incompletely elucidated. Furthermore, some preclinical findings suggest that TNF may even promote cancer development and progression. With this work we intend to summarize the molecular biology of TNF (with particular regard to its tumor-related activities) and review the experimental and clinical evidence currently available describing the complex and sometime apparently conflicting relationship between this cytokine, cancer biology and antitumor therapy. We also propose a model to explain the dual effect of TNF based on the exposure time and cytokine levels reached within the tumor microenvironment. Finally, we overview recent research findings that might lead to new ways for exploiting the anticancer potential of TNF in the clinical setting.
Export Options
About this article
Cite this article as:
Bertazza L. and Mocellin S., The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology, Current Medicinal Chemistry 2010; 17 (29) . https://dx.doi.org/10.2174/092986710793176339
DOI https://dx.doi.org/10.2174/092986710793176339 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Tumor Necrosis Factor-Derived TIP Peptide: A Potential Anti-Edema Drug
Letters in Drug Design & Discovery Attenuation of Hydroxyl Radical Formation by Extracted Constituent of Moringa oleifera Lam
Current Chemical Biology The Plasma and Tissue Kininogen-kallikrein-kinin System: Role in the Cardiovascular System
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Obesity, Metabolic Syndrome, Diabetes and Arterial Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Chymase as an Important Target for Preventing Complications of Metabolic Syndrome
Current Medicinal Chemistry Tolerability of Amine Uptake Inhibitors in Urologic Diseases
Current Drug Safety Angiotensin Converting Enzyme Inhibitor in Coronary Artery Bypass Surgery
Drug Design Reviews - Online (Discontinued) Inhibitory Effect of PD-1/PD-L1 and Blockade Immunotherapy in Leukemia
Combinatorial Chemistry & High Throughput Screening Bothrops Moojeni Venom Peptides Containing Bradykinin Potentiating Peptides Sequences
Protein & Peptide Letters Tumor Necrosis Factor: How to Make a Killer Molecule Tumor-Specific?
Current Cancer Drug Targets Sedation in PACU: The Role of Benzodiazepines
Current Drug Targets Serotonin-2 Receptor Agonists as Novel Ocular Hypotensive Agents and their Cellular and Molecular Mechanisms of Action: Novel Drug Targets for Glaucoma Treatment
Current Drug Targets Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future
Current Topics in Medicinal Chemistry A Review of Chemistry and Pharmacology of Piperidine Alkaloids of Pinus and Related Genera
Current Pharmaceutical Biotechnology The Pharmacogenetics of CYP2C9 and CYP2C19: Ethnic Variation and Clinical Significance
Current Clinical Pharmacology Preclinical Evaluation of New Anthracyclines
Current Medicinal Chemistry Recent Insights into the Role of Prostanoids in Atherosclerotic Vascular Disease
Current Vascular Pharmacology Artery of Percheron Infarction: A Characteristic Pattern of Ischemia and Variable Clinical Presentation: A Literature Review
Current Medical Imaging Seaweed Proteins as a Source of Bioactive Peptides
Current Pharmaceutical Design Organocatalyzed Heterocyclic Transformations In Green Media: A Review
Current Organocatalysis